Controversies in Cardiology
This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines th...
| Published in: | Springer eBooks |
|---|---|
| Corporate Author: | |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edition: | 1st ed. 2015. |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1007/978-3-319-20415-4 Перейти в каталог НБ ТГУ |
| LEADER | 04534nam a22005055i 4500 | ||
|---|---|---|---|
| 001 | vtls000560301 | ||
| 003 | RU-ToGU | ||
| 005 | 20210922090157.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 170212s2015 gw | s |||| 0|eng d | ||
| 020 | |a 9783319204154 |9 978-3-319-20415-4 | ||
| 024 | 7 | |a 10.1007/978-3-319-20415-4 |2 doi | |
| 035 | |a to000560301 | ||
| 039 | 9 | |y 201702122323 |z Александр Эльверович Гилязов | |
| 040 | |a Springer |c Springer |d RU-ToGU | ||
| 050 | 4 | |a RC681-688.2 | |
| 072 | 7 | |a MJD |2 bicssc | |
| 072 | 7 | |a MED010000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.12 |2 23 |
| 245 | 1 | 0 | |a Controversies in Cardiology |h electronic resource |c edited by John A. Ambrose, Alfredo E. Rodríguez. |
| 250 | |a 1st ed. 2015. | ||
| 260 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2015. |9 742221 | ||
| 300 | |a XVIII, 417 p. 53 illus., 41 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women - evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and "normal" coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease - PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes - does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?. | |
| 520 | |a This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients. | ||
| 650 | 0 | |a medicine. |9 566220 | |
| 650 | 0 | |a Cardiology. |9 302215 | |
| 650 | 0 | |a Cardiac Surgery. |9 306628 | |
| 650 | 0 | |a Minimally Invasive Surgery. |9 306165 | |
| 650 | 1 | 4 | |a Medicine & Public Health. |9 566221 |
| 650 | 2 | 4 | |a Cardiology. |9 302215 |
| 650 | 2 | 4 | |a Minimally Invasive Surgery. |9 306165 |
| 650 | 2 | 4 | |a Cardiac Surgery. |9 306628 |
| 700 | 1 | |a Ambrose, John A. |e editor. |9 467270 | |
| 700 | 1 | |a Rodríguez, Alfredo E. |e editor. |9 467271 | |
| 710 | 2 | |a SpringerLink (Online service) |9 143950 | |
| 773 | 0 | |t Springer eBooks | |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-3-319-20415-4 |
| 856 | |y Перейти в каталог НБ ТГУ |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=415044 | ||
| 912 | |a ZDB-2-SME | ||
| 950 | |a Medicine (Springer-11650) | ||
| 999 | |c 415044 |d 415044 | ||